Empowering cell research. Enabling cell therapy.
For 30 years, Miltenyi Biotec has been dedicated to improving scientific understanding and medical progress for clinical research and cell and gene therapy (CGT). Our products and services facilitate the advancement of science, and support clinicians who are bringing new cellular therapies to reality. We specialize in developing tailored cell processing protocols for the fully automated and closed, GMP-compliant CliniMACS Prodigy®. In addition, we offer comprehensive CGT support, including contract development and manufacturing of CGT products and GMP lentiviral vectors.